Literature DB >> 15623725

CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.

J Arii1, T Kanbayashi, Y Tanabe, Y Sawaishi, S Kimura, A Watanabe, K Mishima, Y Hishikawa, T Shimizu, S Nishino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15623725     DOI： 10.1212/01.wnl.0000147328.15956.b4

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.

Authors:  Stine Knudsen; Poul J Jennum; Jørgen Alving; Søren Paludan Sheikh; Steen Gammeltoft
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

2.  Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study.

Authors:  Iñigo Rojas-Marcos; Francesc Graus; Gema Sanz; Arturo Robledo; Carlos Diaz-Espejo
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

3.  CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.

Authors:  Adi Aran; Irina Shors; Ling Lin; Emmanuel Mignot; Michael S Schimmel
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

4.  A case with anti-galactocerebroside antibody-positive Mycoplasma pneumoniae meningoencephalitis presenting secondary hypersomnia.

Authors:  Naoto Sugeno; Norihiko Kawaguchi; Takafumi Hasegawa; Takashi Kuroda; Ichiro Nakashima; Takashi Kanbayashi; Susumu Kusunoki; Masashi Aoki
Journal:  Neurol Sci       Date:  2012-03-15       Impact factor: 3.307

5.  CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Authors:  Takashi Kanbayashi; Tohru Kodama; Hideaki Kondo; Shinsuke Satoh; Yuichi Inoue; Shigeru Chiba; Tetsuo Shimizu; Seiji Nishino
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

6.  Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Francesca Poli; Christian Franceschini; Antonia Parmeggiani; Piero Pirazzoli; Filippo Bernardi; Emmanuel Mignot; Alessandro Cicognani; Pasquale Montagna
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

Review 7.  Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.

Authors:  M A Angulo; M G Butler; M E Cataletto
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.